LOS ANGELES, CA — (Marketwired) — 10/19/16 — Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced results of recent drug formulation studies that documented […]

by

SAN DIEGO, CA–(Marketwired – October 19, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that at The Money Show Dallas, which the Company is sponsoring, Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus will speak to investors about current global cannabis industry […]

by

MELBOURNE, Oct. 19 (Xinhua) — A cannabis pill administered to adults with epilepsy could reduce seizures, Australian researchers said on Wednesday. The drug is the subject of a world-first clinical trial in Australia and New Zealand led by Melbourne researchers. Terry O’Brien, a neurologist at the Royal Melbourne Hospital and head of the trial, said […]

by

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today provided a development update for ZYN001 and ZYN002. Zynerba and its development partner, LTS LOHMANN Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic solutions, are working together to optimize the formulation of ZYN001 into a […]

by

Research into the use of the marijuana derivative cannabidiol (CBD) is just beginning. In an abstract presented at the American Epilepsy Society 69th Annual Meeting in Philadelphia, PA, a team described their ongoing work. Misty Smith, PhD, a research assistant professor at the University of Utah in Salt Lake City, UT, and colleagues are looking […]

by

Phase 1 clinical trial for ZYN001 is expected to begin in 1H17 Topline results for three Phase 2 clinical trials for ZYN002 are on track for 1H17 DEVON, Pa., Oct. 17, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today […]

by

The Multiple Sclerosis Foundation estimates that every week in the U.S., 200 people will learn they have multiple sclerosis (or as it’s more commonly called, MS). People like Jabe Couch, a father and husband from the Pacific Northwest. Few conditions are as long-lasting and progressively debilitating as MS, which causes damage to the brain, spinal […]

by

The Multiple Sclerosis Foundation estimates that every week in the U.S., 200 people will learn they have multiple sclerosis (or as it’s more commonly called, MS). People like Jabe Couch, a father and husband from the Pacific Northwest. Few conditions are as long-lasting and progressively debilitating as MS, which causes damage to the brain, spinal […]

by

SAN DIEGO, CA–(Marketwired – October 14, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company Kannaway, LLC, the first hemp lifestyle network marketing company to offer cannabidiol (CBD) hemp botanical products, is adding a new premium product, Kannaway Premium Hemp Oil, to its line of lifestyle products. The Company will […]

by

Dublin, Aug. 18, 2016 (GLOBE NEWSWIRE) — Research and Markets has announced the addition of the “Global Silicon Photonics Market 2016-2020” report to their offering. The global silicon photonics market to grow at a CAGR of 48.33% during the period 2016-2020. Global Silicon Photonics Market 2016-2020, has been prepared based on an in-depth market analysis […]

by

MORRIS PLAINS, N.J., Aug. 18, 2016 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU) today announced that adding an inhibitor of ATP-binding cassette (ABC) transporters to sacituzumab govitecan, the Company’s lead antibody-drug conjugate (ADC) for solid cancer therapy, increased the median survival of mice bearing a SN-38-resistant human gastric cancer cell line. Results from this preclinical study […]

by

Insys Therapeutics, manufacturer of the synthetic opioid medication fentanyl, made headlines recently when it donated half a million dollars to the anti-cannabis legalization effort in Arizona. Fentanyl is a potent and highly addictive pain killer helping fuel the country’s opioid epidemic and skyrocketing overdose rates. Presumably, Insys is funding anti-legalization efforts because legal cannabis represents […]

by

Insys Therapeutics, manufacturer of the synthetic opioid medication fentanyl, made headlines recently when it donated half a million dollars to the anti-cannabis legalization effort in Arizona. Fentanyl is a potent and highly addictive pain killer helping fuel the country’s opioid epidemic and skyrocketing overdose rates. Presumably, Insys is funding anti-legalization efforts because legal cannabis represents […]

by

Ohio is now one of 26 states to legalize medical marijuana, and a committee appointed by the governor will begin drafting implementation rules this month. Members say one priority is to ensure the state protects the community and the patients who will ultimately use the marijuana products. “We don’t want this to turn into another […]

by

I used cannabis for nausea without realizing it might actually have been the cause of it. Cannabinoid hyperemesis syndrome (also known as cannabis hyperemesis syndrome, or CHS) is a recently discovered, poorly understood condition theoretically caused by heavy, long-term cannabis use. Its acute “hyperemetic” phase is characterized by vomiting, nausea, severe gastrointestinal discomfort, and compulsive […]

by